Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03124303
Other study ID # 2015-0374
Secondary ID A530900SMPH\ANES
Status Recruiting
Phase
First received
Last updated
Start date February 13, 2017
Est. completion date December 2025

Study information

Verified date August 2023
Source University of Wisconsin, Madison
Contact David Kunkel, BS
Phone 608-262-6469
Email dkunkel@wisc.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The IPOD-B3 study aims to characterize the relationship between premorbid brain activity and postoperative delirium in patients undergoing major surgery. This is a expansion of the NeuroVISION Bolt-On study, NCT01980511.


Description:

9/8/21-- Deleted two Outcome Measures pending IRB approval. 11/5/21-- added outcome measures after IRB approval.


Recruitment information / eligibility

Status Recruiting
Enrollment 310
Est. completion date December 2025
Est. primary completion date December 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: - Age =65 years - Anticipated length of hospital stay of at least 2 days after surgery that occurs under general or neuraxial anesthesia - Written Informed Consent for potential participation prior to surgery Exclusion Criteria: - Contraindication to EEG - Unable or unwilling to attend the follow-up appointments - Documented history of dementia - Deemed incapable of providing consent by surgical team - Residing in a nursing home - Undergoing intracranial surgery - Unable to complete neurocognitive testing due to language, vision or hearing impairment - Unable to communicate with the research staff due to language barriers - For optional MRI portion of the study: Contraindication to MRI (e.g., implanted devices not safe for MRI studies, claustrophobia, unable to lie flat or still)

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
High Density-Electroencephalogram
EEG is a safe non-invasive technology without complications that may be used to help diagnose delirium
Magnetic Resonance Imaging
MRI scan of brain

Locations

Country Name City State
United States University of Wisconsin-Madison Madison Wisconsin

Sponsors (2)

Lead Sponsor Collaborator
University of Wisconsin, Madison National Institute on Aging (NIA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Functional Connectivity Change from baseline functional connectivity at immediate postoperative period and association between delirium (CAM) and functional connectivity of the cingulate cortex Pre-operative measure: Up to 4 weeks prior to surgery. Post-operative measure: Post-Operative days 1-4
Secondary Inflammation Assess the changes from preoperative to postoperative EEG associated with delirium and change in plasma/cerebrospinal fluid (CSF) IL-6 or other biomarkers (e.g. other cytokines or markers of neronal injury) Pre-operative measure: Up to 4 weeks prior to surgery. Post-operative measure: POD1-4
Secondary Biomarkers Identify biomarkers of delirium and neural damage through changes in circulating plasma proteins and molecules (through mass spectometry) Post-operative day 1 through 4
Secondary Brain measurements Assess the association between preoperative white matter connectivity (DTI) and cortical thickness (derived from MRI) and postoperative delirium Preoperative MRI will occur up to 4-weeks prior to surgery. Delirium is followed postoperatively, days 1-4
Secondary Long term cognition Examine the incidence of delirium with change in cognition from preoperatively to one-year postoperatively. Pre-operative cognition measures will occur up to 4 weeks prior to surgery. Post-operative delirium measured on postoperative days 1-4. Long term post-operative cognition measured 1 year after surgery.
Secondary Long term cognition Assess the impact of delirium, preoperative and postoperative imaging biomarkers with a change in long term cognition Pre-operative measure: Up to 4 weeks prior to surgery. Post-operative measure: Up to two years after surgery
Secondary Baseline cognition, specific and global. Examine the association between preoperative cognition using a neuropsychological battery, and postoperative delirium incidence. Cognition is assessed preoperatively. Participants are followed for delirium on postoperative days 1-4
Secondary Biomarkers and brain measurements Assess the changes in cognition and biomarkers over one year with EEG changes. Pre-op measures: up to 4 weeks prior to surgery. Post-op measures: one year, and two years, after surgery.
Secondary Representativeness of surgical population Identify whether patients who consent to the MRI are reflective of the surgical population. Pre-op MRI: up to 4 weeks prior to surgery.
Secondary Genetics and delirium Identify genetic and epigenetic changes associated with delirium and its pathogenesis. Pre-op blood collected up to 4 weeks prior to surgery. Post-operative delirium measured on postoperative days 1-4. Post-operative blood collected on postoperative days 1-4. Long term blood collected 90 days and 1 year after surgery.
Secondary Postoperative amyloid beta deposition and delirium Identify associations between delirium and amyloid beta deposition detected by Positron Emission Tomography at 90 days after surgery in sub-study IPOD-PET. Post-operative delirium measured on postoperative days 1-4. PET imaging will occur 90 days after surgery.
Secondary Long term changes in amyloid beta deposition and delirium Identify associations between delirium and amyloid beta deposition detected by Positron Emission Tomography preoperatively and 1 year after surgery in sub-study IPOD-PET2. Pre-operative PET imaging will occur up to 4 weeks prior to surgery. Post-operative delirium measured on postoperative days 1-4. Post-operative PET imaging will occur 1 year after surgery.
Secondary Long term cognition Identify predictors of delirium severity and incidence, for change in cognition from preoperatively to two-years postoperatively. Pre-operative cognition measures will occur up to 4 weeks prior to surgery. Long term post-operative cognition measured 2 years after surgery.
See also
  Status Clinical Trial Phase
Completed NCT04551508 - Delirium Screening 3 Methods Study
Recruiting NCT05891873 - Delirium in the (Neuro)Intensive/Critical Care in the Adult and Paediatric Czech Populations
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT04792983 - Cognition and the Immunology of Postoperative Outcomes
Recruiting NCT06194474 - Study on Biomarkers of Postoperative Delirium in Elderly Cardiac Surgery Patients
Completed NCT03095417 - Improving the Recovery and Outcome Every Day After the ICU N/A
Completed NCT05395559 - Prevalence and Recognition of Cognitive Impairment in Hospitalized Patients: a Flash Mob Study
Terminated NCT03337282 - Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
Not yet recruiting NCT04846023 - Pediatric Delirium Screening in the PICU Via EEG N/A
Not yet recruiting NCT04538469 - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Not yet recruiting NCT03807388 - ReMindCare App for Patients From First Episode of Psychosis Unit. N/A
Withdrawn NCT02673450 - PER3 Clock Gene Polymorphism, Clock Gene Expression and Delirium in the Intensive Care Unit.
Recruiting NCT03256500 - Transcranial Direct Current Stimulation for the Treatment of Delirium N/A
Completed NCT02890927 - Geriatric-CO-mAnagement for Cardiology Patients in the Hospital N/A
Not yet recruiting NCT02892968 - ED Ultrasonographic Regional Anesthesia to Prevent Incident Delirium in Hip Fracture Patients N/A
Recruiting NCT03165539 - Cerebral Oxygen Desaturation and Post-Operative Delirium in Thoracic Surgical Patients
Completed NCT02554253 - The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction Phase 2
Completed NCT02518646 - DElirium prediCtIon in the intenSIve Care Unit: Head to Head comparisON of Two Delirium Prediction Models N/A
Recruiting NCT02305589 - The Clinical Changes Before and After Sugammadex in the Patients Undergoing Hip Surgery on the Aspect of Delirium N/A
Completed NCT02628925 - Nu-DESC DK: The Danish Version of the Nursing Delirium Screening Scale N/A